Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

HIV-associated bacteremia: how it has changed in the highly active antiretroviral therapy (HAART) era

Article Abstract:

Highly active antiretroviral therapy (HAART) has reduced the incidence of bacteremia in HIV patients, according to a survey of bacteremia rates before and after HAART was introduced. Bacteremia is a bacterial infection of the blood.

Author: Tumbarello, Mario, Tacconelli, Evelina, De Gaetano Donati, Katleen, Citton, Rita, Leone, Fiammetta, Spanu, Teresa, Cauda, Roberto
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2000
Statistical Data Included, Statistics, HIV infection, Drug therapy, HIV infections, Bacteremia

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Nosocomial bloodstream infections in HIV-infected patients: attributable mortality and extension of hospital stay

Article Abstract:

Nosocomial bloodstream infections may increase the risk of death in HIV patients. Nosocomial infections are infections that patients develop while they are in a hospital. Researchers analyzed the effect of nosocomial bloodstream infections in 252 HIV hospitalized HIV patients, of whom 84 had a nosocomial bloodstream infection. Serious illness and having a central venous catheter were the most important risk factors for nosocomial bloodstream infection. These infections increased the death rate by 27% and the hospital stay by 17 days.

Author: Tumbarello, Mario, Tacconelli, Evelina, Leone, Fiammetta, Cauda, Roberto, Ortona, Luigi, Donati, Katleen de Gaetano, Morace, Giulia
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology
Subject: Health
ISSN: 1077-9450
Year: 1998
Health aspects, Patient outcomes, Mortality, Hospital utilization, Hospital stays, Septicemia

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: a prospective case-control study

Article Abstract:

Protease inhibitors appear to protect HIV patients against oral Candida infection. This was the conclusion of a study of 93 HIV patients with a history of oral Candida, some of whom took protease inhibitors, some of whom took other AIDS drugs and some of whom took neither. Over a one-year period, 7% of those taking protease inhibitors developed recurring oral Candida infection, compared to 36% of those not taking protease inhibitors.

Author: Tumbarello, Mario, Tacconelli, Evelina, Cauda, Roberto, Cassone, Antonio, Morace, Giulia, De Bernardis, Flavia, Torosantucci, Antonella
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology
Subject: Health
ISSN: 1077-9450
Year: 1999
Care and treatment, Evaluation, Prevention, Protease inhibitors, Thrush (Mouth disease), Oral candidiasis

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: HIV patients
Similar abstracts:
  • Abstracts: Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection
  • Abstracts: Knowledge about vaccines and willingness to participate in preventive HIV vaccine trials: a population-based study, Rakai, Uganda
  • Abstracts: Early pregnancy termination with mifepristone and misoprostol in the United States. Medical termination of pregnancy
  • Abstracts: HIV-1 p24 may persist during long-term highly active antiretroviral therapy, increases little during short treatment breaks, and its rebound after treatment stop correlates with CD4(super +) T cell loss
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.